University of Hawaii Cancer Center — Honolulu, Hawaii

University of Hawaii Cancer Center is a clinical research site located in Honolulu, Hawaii, United States 96813.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Hawaii Cancer Center has participated in 340 clinical trials with 151 currently active.

Therapeutic areas: Breast Cancer, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Sponsors: Eli Lilly and Company, National Cancer Institute (NCI), University of Hawaii.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Hawaii Cancer Center?

University of Hawaii Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Hawaii Cancer Center conducted?

University of Hawaii Cancer Center has 340 clinical trials on record, with 151 currently active. Their work covers Breast Cancer, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Is University of Hawaii Cancer Center accredited by Crixeo Health?

University of Hawaii Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Hawaii Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.